Takeda is to develop a Zika vaccine, backed by up to $312 million in US government funding, joining a host of other organisations racing to find treatments for the disease.<
Theranos’ new blood testing technology was supposed to signal “the beginning of the next phase" for the company, with the promise of a fast diagnostic blood test for Zika virus.
The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio
